iShares Neuroscience and Healthcare ETF
IBRNETF · NYSE Arca
$33.30
+$0.01 (+0.02%)
EOD Oct 30, 2026
Key facts
- Expense ratio
- 0.47%
- Dividend yield (TTM)
- 0.96%
- Distributions
- Annual
- Fund net assets (Jul 2026)
- $5M
- Stocks held
- 68
- Other positions
- 12
- Turnover (last fiscal year)
- 46%
- 52-week range
- $27.70 to $43.01
Top 10 holdings
All holdings41.6% of assets in ten stocks, as of Oct 28, 2026
| Company | Weight | Quality |
|---|---|---|
| 5.17% | 39 | |
| 4.59% | 40 | |
| 4.39% | n/a | |
| 4.37% | 82 | |
| 4.25% | 65 | |
| 4.04% | 67 | |
| 3.80% | 61 | |
| 3.79% | 10 | |
| 3.65% | 10 | |
| 3.56% | 10 |
Sector allocation
Share of the fund's assets
- Healthcare83.9%
- Health Care15.9%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
8% of the fund's stock weight sits in companies with a Quality score above 75, 42% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States75.1%
- Belgium4.0%
- South Korea3.2%
- Sweden3.1%
- Denmark3.1%
- Japan2.4%
- Switzerland2.2%
- Australia2.2%
And 5 more countries.
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyIBRN pays annual. Over the last twelve months it paid $0.32 per share, a 0.96% yield at today's price. The latest payment was $0.32, ex-dividend Dec 16, 2025.
Average annual returns
Total return at net asset value, to Jul 31, 2026, as reported to the SEC
| 1 year | 5 years | 10 years |
|---|---|---|
| 58.35% | 10.27% | n/a |
Past returns say nothing certain about future ones.
IBRN questions
What does IBRN invest in?+
iShares Neuroscience and Healthcare ETF is an exchange-traded fund. Its largest holdings are Biogen Inc. (5.17%), Alkermes plc (4.59%), Edgewise Therapeutics, Inc. (4.39%).
What is IBRN's expense ratio?+
0.47% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $47.00 a year.
How much does IBRN pay in dividends?+
IBRN paid $0.32 per share over the last twelve months, a 0.96% yield at the Oct 30, 2026 close of $33.30. It pays annual.
How good are the companies IBRN owns?+
Weighted by position size, the stocks in IBRN average a Quality score of 40 out of 100. 8% of the fund's stock weight sits in companies scoring above 75, 42% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's own holdings list, published by BlackRock iShares, as of Oct 28, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to Jul 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 30, 2026.